Hospital AI: Epic, Ambient Scribes and FDA Clearances — 2026-09-16
Oracle Health expanded its clinical AI agent to inpatient nurses, while Abridge launched a pre-bill review tool to integrate ambient scribes into revenue cycle workflows. Simultaneously, the FDA cleared LUMA Vision’s integrated cardiac imaging platform, and new data highlighted radiology’s continued lead in AI-enabled medical device approvals.
Hospital AI: Epic, Ambient Scribes and FDA Clearances — 2026-09-16
Top developments
Oracle Health extends clinical AI agent to inpatient nursing workflows
On September 14, 2026, Oracle Health announced the expansion of its generative AI capabilities directly into inpatient nursing workflows within the Oracle Health Foundation EHR. The new Clinical AI Agent combines voice-driven chart navigation, acute nursing summaries, and discrete bedside charting to automate documentation for nurses. This move signals a shift from physician-centric ambient scribes to broader clinical staff automation, aiming to reduce administrative burden across all care team members.
Abridge launches pre-bill AI review for CDI and coding teams
Also on September 14, 2026, Abridge introduced an AI pre-bill review tool designed for Clinical Documentation Improvement (CDI) and coding teams. The tool audits inpatient claims and DRGs against bedside clinical dialogue captured by its ambient scribe technology before billing occurs. This integration represents a significant evolution of ambient AI from mere documentation support to a direct revenue integrity mechanism, potentially reducing claim denials and improving reimbursement accuracy.
FDA clears LUMA Vision’s integrated cardiac imaging platform
The FDA recently cleared LUMA Vision’s VERAFEYE platform, expanding its capabilities for real-time cardiac imaging and catheter guidance in minimally invasive procedures. This clearance adds to the growing list of FDA-approved AI-enabled devices in cardiology, a specialty seeing rapid adoption of diagnostic algorithms. The integration of real-time imaging guidance with AI-driven analysis supports more precise interventions and may streamline procedural workflows.
Radiology maintains lead in FDA AI approvals
New data released by the FDA indicates that radiology continues to maintain its lead in FDA approvals for AI-enabled medical devices. As of September 2026, radiology remains the dominant specialty for AI authorizations, reflecting the maturity of imaging algorithms compared to other fields. This trend underscores the ongoing focus on diagnostic accuracy and workflow efficiency in radiology departments, where AI tools are increasingly embedded in daily practice.
Local view
In Japan, Kitasato University Hospital announced the adoption of Ubie’s generative AI system, "Yubii Generative AI," scheduled to coincide with their electronic medical record switch in January 2027. The system will support document creation based on multiple clinical records, accessible via mobile devices to enhance physician-patient interaction time. Additionally, the Japanese Ministry of Health, Labour and Welfare emphasized that 100% electronic medical record adoption is not the final goal but part of a broader plan to make healthcare "AI Ready."
Context & numbers
- Abridge Valuation: Abridge has reached a $5.3 billion valuation with over $100 million in annual recurring revenue (ARR), deployed in 250+ health systems.
- VA Expansion: The U.S. Department of Veterans Affairs is gradually expanding its use of medical AI scribes following successful pilots, aiming for an enterprise contract in 2026.
- NHS Procurement: NHS Shared Business Services has launched a £900 million framework agreement to support the procurement of AI across the NHS, emphasizing ethical performance metrics.
On the radar
- Kitasato University Hospital: Watch for the January 2027 go-live of Ubie’s generative AI integration with their new EMR system.
- NHS Equity Frameworks: New proposals urge DHSC and NHS England to make anti-racism and ethnicity performance data determining factors in future AI procurement tenders.
- VA Enterprise Contract: Anticipate details on the VA’s upcoming enterprise contract for AI scribes, which could set standards for federal healthcare AI adoption.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
